247 related articles for article (PubMed ID: 3874925)
1. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes.
Oshimi K; Oshimi Y; Satake M; Mizoguchi H
J Exp Med; 1985 Aug; 162(2):472-86. PubMed ID: 3874925
[TBL] [Abstract][Full Text] [Related]
2. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
3. Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms.
Burns GF; Triglia T; Bartlett PF; Mackay IR
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7606-10. PubMed ID: 6608725
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
6. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
7. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells.
Einhorn S; Anderbring E
J Clin Lab Immunol; 1985 Apr; 16(4):197-9. PubMed ID: 4020850
[TBL] [Abstract][Full Text] [Related]
8. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
9. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
Itoh K; Platsoucas CD; Balch CM
Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
[TBL] [Abstract][Full Text] [Related]
10. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
11. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
12. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
Richter M; Kazaniwsky N
Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
[TBL] [Abstract][Full Text] [Related]
13. Lysis of leukemia and lymphoma cells by autologous and allogeneic interferon-activated blood mononuclear cells.
Oshimi K; Oshimi Y; Motoji T; Kobayashi S; Mizoguchi H
Blood; 1983 Apr; 61(4):790-8. PubMed ID: 6831042
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
15. Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells.
Pattengale PK; Gidlund M; Nilsson K; Sundström C; Orn A; Wigzell H
Int J Cancer; 1981 Oct; 28(4):459-68. PubMed ID: 6171529
[TBL] [Abstract][Full Text] [Related]
16. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
Uchida A; Micksche M
Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
[TBL] [Abstract][Full Text] [Related]
17. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
18. [Natural killer cells lysing the blood B-lymphocytes of patients with chronic lympholeukemia].
Khonina NA; Shubinskiĭ GZ
Eksp Onkol; 1988; 10(4):44-6. PubMed ID: 3263265
[TBL] [Abstract][Full Text] [Related]
19. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
20. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
Atzpodien J; Gulati SC
Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
